{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:34:46Z","timestamp":1790663686490,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["19-74-20161"],"award-info":[{"award-number":["19-74-20161"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["19-74-20161"],"award-info":[{"award-number":["19-74-20161"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["19-74-20161"],"award-info":[{"award-number":["19-74-20161"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["19-74-20161"],"award-info":[{"award-number":["19-74-20161"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["19-74-20161"],"award-info":[{"award-number":["19-74-20161"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["19-74-20161"],"award-info":[{"award-number":["19-74-20161"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cancer cell resistance and tumor relapse remain major challenges in cancer treatment. Chloroquine, an FDA-approved antimalarial drug currently undergoing clinical trials for various cancers, has emerged as a promising candidate for combination therapy with conventional anticancer agents. In this study, we demonstrate that in patients-derived osteosarcoma cells who had undergone multiple chemotherapy treatments, as well as in murine colorectal cancer cells, administration of standard chemotherapeutic agents induces autophagy, which likely serves as a cytoprotective mechanism promoting therapy resistance in at least of part of tumor population. Incorporating chloroquine into the treatment regimen effectively suppressed autophagy, significantly enhancing osteosarcoma cell death in both 2D and 3D models while simultaneously reducing cell proliferation and migration capacity. In an orthotopic in vivo model of colorectal cancer, the combination of chloroquine and oxaliplatin not only impaired tumor growth but also prevented metastatic dissemination and inhibited the formation of metastasis. Notably, comparative analyses of proliferating and dormant tumor cell populations revealed that chloroquine exerts preferential cytotoxicity toward dormant cancer cells. This suggests a dual therapeutic advantage, wherein cytostatic agents primarily eliminate proliferating cells, while chloroquine specifically eradicates dormant cancer cells, which are often implicated in tumor recurrence. Collectively, these findings highlight the potential of autophagy inhibition to enhance the chemotherapy efficacy and suggest chloroquine-based combination therapy as a promising strategy for suppressing tumor growth and metastasis, ultimately improving treatment outcomes in cancer patients.<\/jats:p>","DOI":"10.1038\/s41419-025-08304-6","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T02:03:50Z","timestamp":1765332230000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Chloroquine Overcomes Chemotherapy Resistance and Suppresses Cancer Metastasis by Eradicating Dormant Cancer Cells"],"prefix":"10.1038","volume":"17","author":[{"given":"Marina A.","family":"Mikeladze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liubov S.","family":"Kuznetcova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Y.","family":"Komarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3176-281X","authenticated-orcid":false,"given":"Margarita A.","family":"Galcheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7117-6789","authenticated-orcid":false,"given":"Vladimir F.","family":"Lazarev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9673-8494","authenticated-orcid":false,"given":"Lev A.","family":"Khamaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Konanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yana A.","family":"Gladova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4796-0386","authenticated-orcid":false,"given":"Anna B.","family":"Danilova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2608-0147","authenticated-orcid":false,"given":"Boris A.","family":"Margulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2239-2872","authenticated-orcid":false,"given":"Bashar A.","family":"Alhasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8775-7713","authenticated-orcid":false,"given":"Irina V.","family":"Guzhova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"8304_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s40744-016-0050-2","volume":"4","author":"BA Lindsey","year":"2017","unstructured":"Lindsey BA, Markel JE, Kleinerman ES. Osteosarcoma Overview. Rheumatol Ther. 2017;4:25\u201343.","journal-title":"Rheumatol Ther"},{"key":"8304_CR2","doi-asserted-by":"crossref","unstructured":"Otani S, Ohnuma M, Ito K, Matsushita Y. Cellular dynamics of distinct skeletal cells and the development of osteosarcoma. Front Endocrinol (Lausanne). 2023;14.","DOI":"10.3389\/fendo.2023.1181204"},{"key":"8304_CR3","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.ctrv.2013.11.006","volume":"40","author":"A Luetke","year":"2014","unstructured":"Luetke A, Meyers PA, Lewis I, Juergens H. Osteosarcoma treatment - Where do we stand? A state of the art review. Cancer Treat Rev. 2014;40:523\u201332.","journal-title":"Cancer Treat Rev"},{"key":"8304_CR4","first-page":"233","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73:233\u201354.","journal-title":"CA Cancer J Clin"},{"key":"8304_CR5","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/jama.2021.0106","volume":"325","author":"LH Biller","year":"2021","unstructured":"Biller LH, Schrag D. Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA. 2021;325:669\u201385.","journal-title":"JAMA"},{"key":"8304_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","volume":"34","author":"A Cervantes","year":"2023","unstructured":"Cervantes A, Adam R, Rosell\u00f3 S, Arnold D, Normanno N, Ta\u00efeb J, et al. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34:10\u201332.","journal-title":"Ann Oncol"},{"key":"8304_CR7","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nrc3599","volume":"13","author":"C Holohan","year":"2013","unstructured":"Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG. Cancer drug resistance: an evolving paradigm. Nat Rev Cancer. 2013;13:714\u201326.","journal-title":"Nat Rev Cancer"},{"key":"8304_CR8","first-page":"275","volume":"205","author":"DB Longley","year":"2005","unstructured":"Longley DB, Johnston PG. Molecular mechanisms of drug resistance. J Pathol A J Pathol Soc Gt Britain Irel. 2005;205:275\u201392.","journal-title":"J Pathol A J Pathol Soc Gt Britain Irel"},{"key":"8304_CR9","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nrd.2017.22","volume":"16","author":"L Galluzzi","year":"2017","unstructured":"Galluzzi L, Bravo-San Pedro JM, Levine B, Green DR, Kroemer G. Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles. Nat Rev Drug Discov. 2017;16:487\u2013511.","journal-title":"Nat Rev Drug Discov"},{"key":"8304_CR10","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021108863","volume":"40","author":"DJ Klionsky","year":"2021","unstructured":"Klionsky DJ, Petroni G, Amaravadi RK, Baehrecke EH, Ballabio A, Boya P, et al. Autophagy in major human diseases. EMBO J. 2021;40:e108863.","journal-title":"EMBO J"},{"key":"8304_CR11","doi-asserted-by":"crossref","unstructured":"Goldsmith J, Levine B, Debnath J. Chapter Two - Autophagy and Cancer Metabolism. In: Galluzzi L, Kroemer GBTM in E, editors. Conceptual Background and Bioenergetic\/Mitochondrial Aspects of Oncometabolism. Academic Press; 2014. p. 25\u201357.","DOI":"10.1016\/B978-0-12-416618-9.00002-9"},{"key":"8304_CR12","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.tcb.2018.04.002","volume":"28","author":"I Elia","year":"2018","unstructured":"Elia I, Doglioni G, Fendt SM. Metabolic Hallmarks of Metastasis Formation. Trends Cell Biol. 2018;28:673\u201384.","journal-title":"Trends Cell Biol"},{"key":"8304_CR13","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1038\/onc.2016.333","volume":"36","author":"EE Mowers","year":"2017","unstructured":"Mowers EE, Sharifi MN, Macleod KF. Autophagy in cancer metastasis. Oncogene. 2017;36:1619\u201330.","journal-title":"Oncogene"},{"key":"8304_CR14","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrc3793","volume":"14","author":"MS Sosa","year":"2014","unstructured":"Sosa MS, Bragado P, Aguirre-Ghiso JA. Mechanisms of disseminated cancer cell dormancy: an awakening field. Nat Rev Cancer. 2014;14:611\u201322.","journal-title":"Nat Rev Cancer"},{"key":"8304_CR15","doi-asserted-by":"publisher","first-page":"e74407","DOI":"10.1371\/journal.pone.0074407","volume":"8","author":"YF Peng","year":"2013","unstructured":"Peng YF, Shi YH, Shen YH, Ding ZB, Ke AW, Zhou J, et al. Promoting Colonization in Metastatic HCC Cells by Modulation of Autophagy. PLoS One. 2013;8:e74407.","journal-title":"PLoS One"},{"key":"8304_CR16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10555-023-10085-3","volume":"42","author":"B Alhasan","year":"2023","unstructured":"Alhasan B, Mikeladze M, Guzhova I, Margulis B. Autophagy, molecular chaperones, and unfolded protein response as promoters of tumor recurrence. Cancer Metastasis Rev. 2023;42:217\u201354.","journal-title":"Cancer Metastasis Rev"},{"key":"8304_CR17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s12016-010-8243-x","volume":"42","author":"I Ben-Zvi","year":"2012","unstructured":"Ben-Zvi I, Kivity S, Langevitz P, Shoenfeld Y. Hydroxychloroquine: From Malaria to Autoimmunity. Clin Rev Allergy Immunol. 2012;42:145\u201353.","journal-title":"Clin Rev Allergy Immunol"},{"key":"8304_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/mabi.202100233","volume":"21","author":"S Xu","year":"2021","unstructured":"Xu S, Zhong Y, Nie C, Pan Y, Adeli M, Haag R. Co-delivery of doxorubicin and chloroquine by polyglycerol functionalized MoS2 nanosheets for efficient multidrug-resistant cancer therapy. Macromol Biosci. 2021;21:2100233.","journal-title":"Macromol Biosci"},{"key":"8304_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.bbrc.2023.03.048","volume":"656","author":"N Bano","year":"2023","unstructured":"Bano N, Ansari MI, Kainat KM, Singh VK, Sharma PK. Chloroquine synergizes doxorubicin efficacy in cervical cancer cells through flux impairment and down regulation of proteins involved in the fusion of autophagosomes to lysosomes. Biochem Biophys Res Commun. 2023;656:131\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"8304_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13569-020-0125-2","volume":"10","author":"A Danilova","year":"2020","unstructured":"Danilova A, Misyurin V, Novik A, Girdyuk D, Avdonkina N, Nekhaeva T, et al. Cancer\/testis antigens expression during cultivation of melanoma and soft tissue sarcoma cells. Clin Sarcoma Res. 2020;10:3.","journal-title":"Clin Sarcoma Res"},{"key":"8304_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-00734-4","volume":"11","author":"EY Komarova","year":"2021","unstructured":"Komarova EY, Suezov RV, Nikotina AD, Aksenov ND, Garaeva LA, Shtam TA, et al. Hsp70-containing extracellular vesicles are capable of activating of adaptive immunity in models of mouse melanoma and colon carcinoma. Sci Rep. 2021;11:21314.","journal-title":"Sci Rep"},{"key":"8304_CR22","doi-asserted-by":"crossref","unstructured":"Pervushin N V, Yapryntseva MA, Panteleev MA, Zhivotovsky B, Kopeina GS. Cisplatin Resistance and Metabolism: Simplification of Complexity. Vol. 16, Cancers. 2024.","DOI":"10.3390\/cancers16173082"},{"key":"8304_CR23","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/cam4.3610","volume":"10","author":"A Perret","year":"2021","unstructured":"Perret A, D\u00f4mont J, Chamseddine AN, Dumont SN, Verret B, Briand S, et al. Efficacy and safety of oral metronomic etoposide in adult patients with metastatic osteosarcoma. Cancer Med. 2021;10:230\u20136.","journal-title":"Cancer Med"},{"key":"8304_CR24","doi-asserted-by":"crossref","unstructured":"Kuang Z, Wang J, Liu K, Wu J, Li J. Optimal duration of oxaliplatin-based adjuvant chemotherapy in patients with different risk factors for stage II\u2013III colon cancer: a meta-analysis. Int J Surg. 2024;110.","DOI":"10.1097\/JS9.0000000000001175"},{"key":"8304_CR25","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202401409R","volume":"38","author":"D Li","year":"2024","unstructured":"Li D, Geng D, Wang M. Advances in natural products modulating autophagy influenced by cellular stress conditions and their anticancer roles in the treatment of ovarian cancer. FASEB J. 2024;38:e70075.","journal-title":"FASEB J"},{"key":"8304_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116277","volume":"225","author":"M Skrzeszewski","year":"2024","unstructured":"Skrzeszewski M, Maciejewska M, Kobza D, Gawrylak A, Kieda C, Wa\u015b H. Risk factors of using late-autophagy inhibitors: Aspects to consider when combined with anticancer therapies. Biochem Pharmacol. 2024;225:116277.","journal-title":"Biochem Pharmacol"},{"key":"8304_CR27","doi-asserted-by":"crossref","unstructured":"Nikotina AD, Vladimirova SA, Kokoreva NE, Komarova EY, Aksenov ND, Efremov S, et al. Combined Cytotoxic Effect of Inhibitors of Proteostasis on Human Colon Cancer Cells. Vol. 15, Pharmaceuticals. 2022.","DOI":"10.3390\/ph15080923"},{"key":"8304_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03449-6","volume":"12","author":"Z Liu","year":"2021","unstructured":"Liu Z, Wang H, Hu C, Wu C, Wang J, Hu F, et al. Targeting autophagy enhances atezolizumab-induced mitochondria-related apoptosis in osteosarcoma. Cell Death Dis. 2021;12:164.","journal-title":"Cell Death Dis"},{"key":"8304_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-03875-8","volume":"12","author":"MP Liebl","year":"2022","unstructured":"Liebl MP, Meister SC, Frey L, Hendrich K, Klemmer A, Wohlfart B, et al. Robust LC3B lipidation analysis by precisely adjusting autophagic flux. Sci Rep. 2022;12:79.","journal-title":"Sci Rep"},{"key":"8304_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2024.100635","volume":"48","author":"A Barzegari","year":"2024","unstructured":"Barzegari A, Salemi F, Kamyab A, Aratikatla A, Nejati N, Valizade M, et al. The efficacy and applicability of chimeric antigen receptor (CAR) T cell-based regimens for primary bone tumors: A comprehensive review of current evidence. J Bone Oncol. 2024;48:100635.","journal-title":"J Bone Oncol"},{"key":"8304_CR31","doi-asserted-by":"crossref","unstructured":"Krzywo\u0144 L, Lazaris A, Petrillo SK, Zlotnik O, Gao ZH, Metrakos P. Histopathological growth patterns determine the outcomes of colorectal cancer liver metastasis following liver resection. Vol. 16, Cancers. 2024.","DOI":"10.3390\/cancers16183148"},{"key":"8304_CR32","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.ccell.2016.11.002","volume":"30","author":"S Ebinger","year":"2016","unstructured":"Ebinger S, \u00d6zdemir EZ, Ziegenhain C, Tiedt S, Castro Alves C, Grunert M, et al. Characterization of rare, dormant, and therapy-resistant cells in acute lymphoblastic leukemia. Cancer Cell. 2016;30:849\u201362.","journal-title":"Cancer Cell"},{"key":"8304_CR33","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1080\/15384101.2015.1014145","volume":"14","author":"AT Bui","year":"2015","unstructured":"Bui AT, Laurent F, Havard M, Dautry F, Tch\u00e9nio T. SMAD signaling and redox imbalance cooperate to induce prostate cancer cell dormancy. Cell Cycle. 2015;14:1218\u201331.","journal-title":"Cell Cycle"},{"key":"8304_CR34","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1080\/15384101.2022.2123187","volume":"22","author":"C Nicco","year":"2023","unstructured":"Nicco C, Thomas M, Guillermet J, Havard M, Laurent-Tchenio F, Doridot L, et al. Mechanistic target of rapamycin (mTOR) regulates self-sustained quiescence, tumor indolence, and late clinical metastasis in a Beclin-1-dependent manner. Cell Cycle. 2023;22:542\u201364.","journal-title":"Cell Cycle"},{"key":"8304_CR35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10555-023-10096-0","volume":"42","author":"JL Kirkland","year":"2023","unstructured":"Kirkland JL. Tumor dormancy and disease recurrence. Cancer Metastasis Rev. 2023;42:9\u201312.","journal-title":"Cancer Metastasis Rev"},{"key":"8304_CR36","doi-asserted-by":"crossref","unstructured":"Nikotina AD, Koludarova L, Komarova EY, Mikhaylova ER, Aksenov ND, Suezov R, et al. Discovery and optimization of cardenolides inhibiting HSF1 activation in human colon HCT-116 cancer cells. Oncotarget; Vol 9, No 43. 2018.","DOI":"10.18632\/oncotarget.25545"},{"key":"8304_CR37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00262-023-03612-2","volume":"73","author":"AD Nikotina","year":"2024","unstructured":"Nikotina AD, Vladimirova SA, Kokoreva NE, Nevdakha VA, Lazarev VF, Kuznetcova LS, et al. Novel mechanism of drug resistance triggered by tumor-associated macrophages through Heat Shock Factor-1 activation. Cancer Immunol Immunother. 2024;73:25.","journal-title":"Cancer Immunol Immunother"},{"key":"8304_CR38","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","volume":"24","author":"J Debnath","year":"2023","unstructured":"Debnath J, Gammoh N, Ryan KM. Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol. 2023;24:560\u201375.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8304_CR39","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1158\/1078-0432.CCR-12-1542","volume":"19","author":"M Selvakumaran","year":"2013","unstructured":"Selvakumaran M, Amaravadi RK, Vasilevskaya IA, O\u2019Dwyer PJ. Autophagy inhibition sensitizes colon cancer cells to antiangiogenic and cytotoxic therapy. Clin Cancer Res. 2013;19:2995\u20133007.","journal-title":"Clin Cancer Res"},{"key":"8304_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03733-5","volume":"12","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Huang S, Chen S, Chen J, Wang Z, Wang Y, et al. SOX2 promotes chemoresistance, cancer stem cells properties, and epithelial\u2013mesenchymal transition by \u03b2-catenin and Beclin1\/autophagy signaling in colorectal cancer. Cell Death Dis. 2021;12:449.","journal-title":"Cell Death Dis"},{"key":"8304_CR41","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1080\/15548627.2022.2150003","volume":"19","author":"J Niu","year":"2023","unstructured":"Niu J, Yan T, Guo W, Wang W, Ren T, Huang Y, et al. The COPS3-FOXO3 positive feedback loop regulates autophagy to promote cisplatin resistance in osteosarcoma. Autophagy. 2023;19:1693\u2013710.","journal-title":"Autophagy"},{"key":"8304_CR42","doi-asserted-by":"publisher","first-page":"17901","DOI":"10.18632\/aging.203196","volume":"13","author":"C Chen","year":"2021","unstructured":"Chen C, Zhang H, Yu Y, Huang Q, Wang W, Niu J, et al. Chloroquine suppresses proliferation and invasion and induces apoptosis of osteosarcoma cells associated with inhibition of phosphorylation of STAT3. Aging (Albany NY). 2021;13:17901.","journal-title":"Aging (Albany NY)"},{"key":"8304_CR43","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1038\/s41401-023-01112-8","volume":"44","author":"HL Wang","year":"2023","unstructured":"Wang HL, Li JN, Kan WJ, Xu GY, Luo GH, Song N, et al. Chloroquine enhances the efficacy of chemotherapy drugs against acute myeloid leukemia by inactivating the autophagy pathway. Acta Pharmacol Sin. 2023;44:2296\u2013306.","journal-title":"Acta Pharmacol Sin"},{"key":"8304_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-02988-8","volume":"11","author":"EJ Yun","year":"2020","unstructured":"Yun EJ, Kim S, Hsieh JT, Baek ST. Wnt\/\u03b2-catenin signaling pathway induces autophagy-mediated temozolomide-resistance in human glioblastoma. Cell Death Dis. 2020;11:771.","journal-title":"Cell Death Dis"},{"key":"8304_CR45","doi-asserted-by":"crossref","unstructured":"Alhasan B, Gladova YA, Sverchinsky D V, Aksenov ND, Margulis BA, Guzhova I V. Hsp70 Negatively Regulates Autophagy via Governing AMPK Activation, and Dual Hsp70-Autophagy Inhibition Induces Synergetic Cell Death in NSCLC Cells. Vol. 25, International Journal of Molecular Sciences. 2024.","DOI":"10.3390\/ijms25169090"},{"key":"8304_CR46","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/s41418-024-01310-9","volume":"31","author":"GDS Ferretti","year":"2024","unstructured":"Ferretti GDS, Quaas CE, Bertolini I, Zuccotti A, Saatci O, Kashatus JA, et al. HSP70-mediated mitochondrial dynamics and autophagy represent a novel vulnerability in pancreatic cancer. Cell Death Differ. 2024;31:881\u201396.","journal-title":"Cell Death Differ"},{"key":"8304_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09775-y","volume":"22","author":"A Salimi","year":"2022","unstructured":"Salimi A, Schroeder KM, Schemionek-Reinders M, Vieri M, Maletzke S, Gezer D, et al. Targeting autophagy increases the efficacy of proteasome inhibitor treatment in multiple myeloma by induction of apoptosis and activation of JNK. BMC Cancer. 2022;22:735.","journal-title":"BMC Cancer"},{"key":"8304_CR48","doi-asserted-by":"publisher","first-page":"e0289904","DOI":"10.1371\/journal.pone.0289904","volume":"19","author":"K Zafeiropoulou","year":"2024","unstructured":"Zafeiropoulou K, Kalampounias G, Alexis S, Anastasopoulos D, Symeonidis A, Katsoris P. Autophagy and oxidative stress modulation mediate Bortezomib resistance in prostate cancer. PLoS One. 2024;19:e0289904.","journal-title":"PLoS One"},{"key":"8304_CR49","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.clbc.2020.09.015","volume":"21","author":"K Anand","year":"2021","unstructured":"Anand K, Niravath P, Patel T, Ensor J, Rodriguez A, Boone T, et al. A phase II study of the efficacy and safety of chloroquine in combination with taxanes in the treatment of patients with advanced or metastatic anthracycline-refractory breast cancer. Clin Breast Cancer. 2021;21:199\u2013204.","journal-title":"Clin Breast Cancer"},{"key":"8304_CR50","doi-asserted-by":"crossref","unstructured":"Sasaki K, Tsuno NH, Sunami E, Kawai K, Hongo K, Hiyoshi M, et al. Resistance of colon cancer to 5-fluorouracil may be overcome by combination with chloroquine, an in vivo study. Anticancer Drugs. 2012;23.","DOI":"10.1097\/CAD.0b013e328353f8c7"},{"key":"8304_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbior.2022.100917","volume":"87","author":"JA McCubrey","year":"2023","unstructured":"McCubrey JA, Abrams SL, Follo MY, Manzoli L, Ratti S, Martelli AM, et al. Effects of chloroquine and hydroxychloroquine on the sensitivity of pancreatic cancer cells to targeted therapies. Adv Biol Regul. 2023;87:100917.","journal-title":"Adv Biol Regul"},{"key":"8304_CR52","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.kjms.2017.01.004","volume":"33","author":"YC Lin","year":"2017","unstructured":"Lin YC, Lin JF, Wen SI, Yang SC, Tsai TF, Chen HE, et al. Chloroquine and hydroxychloroquine inhibit bladder cancer cell growth by targeting basal autophagy and enhancing apoptosis. Kaohsiung J Med Sci. 2017;33:215\u201323.","journal-title":"Kaohsiung J Med Sci"},{"key":"8304_CR53","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1172\/JCI28833","volume":"117","author":"RK Amaravadi","year":"2007","unstructured":"Amaravadi RK, Yu D, Lum JJ, Bui T, Christophorou MA, Evan GI, et al. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest. 2007;117:326\u201336.","journal-title":"J Clin Invest"},{"key":"8304_CR54","doi-asserted-by":"crossref","unstructured":"Casagrande N, Borghese C, Avanzo M, Aldinucci D. In doxorubicin-adapted Hodgkin lymphoma cells, acquiring multidrug resistance and improved immunosuppressive abilities, doxorubicin activity was enhanced by chloroquine and GW4869. Cells. 2023;12.","DOI":"10.3390\/cells12232732"},{"key":"8304_CR55","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.cell.2023.03.003","volume":"186","author":"S Gerstberger","year":"2023","unstructured":"Gerstberger S, Jiang Q, Ganesh K. Metastasis. Cell. 2023;186:1564\u201379.","journal-title":"Cell"},{"key":"8304_CR56","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00432-014-1628-0","volume":"140","author":"M Kaneko","year":"2014","unstructured":"Kaneko M, Nozawa H, Hiyoshi M, Tada N, Murono K, Nirei T, et al. Temsirolimus and chloroquine cooperatively exhibit a potent antitumor effect against colorectal cancer cells. J Cancer Res Clin Oncol. 2014;140:769\u201381.","journal-title":"J Cancer Res Clin Oncol"},{"key":"8304_CR57","first-page":"197","volume":"42","author":"F Francescangeli","year":"2023","unstructured":"Francescangeli F, De Angelis ML, Rossi R, Cuccu A, Giuliani A, De Maria R, et al. Dormancy, stemness, and therapy resistance: interconnected players in cancer evolution. Cancer Metastasis Rev. 2023;42:197\u2013215.","journal-title":"Cancer Metastasis Rev"}],"updated-by":[{"DOI":"10.1038\/s41419-026-08552-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000}}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08304-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08304-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08304-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T07:02:50Z","timestamp":1776495770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08304-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8304"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-08304-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6237822\/v1","asserted-by":"object"}]},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"16 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: During an internal final review of the article, we identified an unintended duplication within one of the blot areas in Figure 1; specifically, the ATG5 blot in Figure 1G and 1H was inadvertently duplicated during figure assembly.","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":10,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":11,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41419-026-08552-0","URL":"https:\/\/doi.org\/10.1038\/s41419-026-08552-0","order":13,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All in vivo experimental protocols were approved by the licensing committee of the Institute of Cytology of the Russian Academy of Sciences (Identification number F18-00380). All methods were carried out in accordance with relevant guidelines and regulations and are reported in accordance with ARRIVE guidelines. The research protocol for receiving cells from patients was approved by the local ethical committee, and all patients provided written informed consent prior to tissue collection. Tumor samples were preserved in compliance with the Helsinki Declaration and utilized in accordance with the Human Tissue Act of 2004.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"91"}}